Hajebi, G., Mortazavi, S. (2010). An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions. Iranian Journal of Pharmaceutical Research, Volume 1(Number 1), 15-19.
G Hajebi; SA Mortazavi. "An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions". Iranian Journal of Pharmaceutical Research, Volume 1, Number 1, 2010, 15-19.
Hajebi, G., Mortazavi, S. (2010). 'An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions', Iranian Journal of Pharmaceutical Research, Volume 1(Number 1), pp. 15-19.
Hajebi, G., Mortazavi, S. An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions. Iranian Journal of Pharmaceutical Research, 2010; Volume 1(Number 1): 15-19.
An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions
Drug therapy is a complex and important process and because of the importance of drug interactions, especially in in-patients, accompanying problems and obstacles would exist as a result of concomitant use of drugs in these patients. For this purpose 3130 prescription order forms from Bou-Ali hospital were collected and all potential drug interactions presentwere extracted and evaluated in terms of significance, severity, documentation and onset.
Interactions were divided into 5 groups based on their significance, with group 1 being the most important and group 5 the least important.
Most interactions observed belonged to groups 4 and 5, accounting for 68.5% of all interactions.Group 1 interactions only accounted for 7.8% of all interactions observed.
When considering the onset of interactions, the most dominant type (55.8% of all interactions) were the slow-occurring ones. In terms of the severity, most interactions (47.2%) were of the medium (moderate) type. Strong (severe) interactions only accounted for 8.2% of all interactions.
Finally, in terms of the documentation of interactions, the most prevalent type were the probable ones, accounting for 56.8% of all interactions observed. Definite interactions only accounted for 4.3% of all interactions.
An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions
Iranian Journal of Pharmaceutical Research 2002, 1: 15-19
Received: February 2002
Accepted: July 2002
Original Article
An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions
Giti Hajebi*, Seyed Alireza Mortazavi
Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran.
* ghajebi@yahoo.com
Abstract
Drug therapy is a complex and important process and because of the importance of drug interactions, especially in in-patients, accompanying problems and obstacles would exist as a result of concomitant use of drugs in these patients. For this purpose 3130 prescription order forms from Bou-Ali hospital were collected and all potential drug interactions present were extracted and evaluated in terms of significance, severity, documentation and onset.
Interactions were divided into 5 groups based on their significance, with group 1 being the most important and group 5 the least important.
Most interactions observed belonged to groups 4 and 5, accounting for 68.5% of all interactions.Group 1 interactions only accounted for 7.8% of all interactions observed.
When considering the onset of interactions, the most dominant type (55.8% of all interactions) were the slow-occurring ones. In terms of the severity, most interactions (47.2%) were of the medium (moderate) type. Strong (severe) interactions only accounted for 8.2% of all interactions.
Finally, in terms of the documentation of interactions, the most prevalent type were the probable ones, accounting for 56.8% of all interactions observed. Definite interactions only accounted for 4.3% of all interactions.
Keywords: Drug interaction; Hospital prescription; Prescription; Significance of interaction.
Introduction
Concomitant use of several drugs for a patient is often necessary for achieving a set goal or in cases when the patient is suffering from more than one disease. In these cases the chance of encountering drug - drug interactions could increase (1).
The term "drug interaction" is used when the effects of a drug in the presence of other drugs, food, beverages or environmental and chemical factors, alters (2).
The clinical output of such interactions could appear as antagonism, synergism or idiosyncratism (3).
In a study by Galley et al., it was found that from a total number of 160 patients in the internal ward, 221 cases of interaction exists, in which 24 were of the major type, 115 of the moderate type and 82 minor interactions. In addition it was found that the presence of certain diseases such as kidney failure, or the use of more than 6 drug items, could increase the probability of drug
interactions (4).
In another study by Borda et al., drug interactions in the in-patients of various wards were studied. These interactions accounted for 22% of all cases of drug-drug interactions observed in the hospital (5).
Dipiro and Sislay found in another study that most interactions observed in hospital with patients undergone surgery is due to H2-blockers (especially cimetidine), digoxin and warfarin with the anesthetic drugs (6). Finally, Stanszex and Franklin found that drug interactions in out-patients amounts to 23% of all cases of drug interactions studied (7).
Therefore, because of the importance of drug - drug interactions, in this study attempts were made to investigate the occurrence and extent of drug interactions in the prescriptions of ICU, CCU, internal and infectious wards of Bou-Ali teaching hospital, Tehran, Iran.
Experimental
In this study the extent of occurrence and frequency of potential drug interactions were investigated based on the reference text "Drug Interaction Facts". This particular reference was used because of its extensive and unique classifications of drug interactions.
In this study a total number of 3130 prescriptions from in-patients of ICU, CCU, internal and infectious wards of Bou?Ali teaching hospital were examined during the first 6 months of 2000 and all the potential drug interactions present were extracted and classified in terms of significance, onset, severity and documentation.
Results
Among the prescriptions examined 3960 cases and 156 types of interaction were observed.
Table 1. A summary of
prescriptions evaluated in various wards of Bou-Ali hospital.
Ward
Number of prescriptions
Number of interactions
Type of interactions
Number of prescribed drugs
Mean number of
drugs prescribed
CCU
400
598
80
40
5.0
ICU
380
342
58
32
5.7
Internal
1250
1763
151
58
4.4
Infectious
1100
1257
131
39
4.2
Table 1 shows the overall results obtained from assessing prescriptions of various wards. The overall results obtained in terms of significance, onset, severity and documentation are shown in Tables 2-5 and can be summarised as follows:
In terms of the significance, the most frequent interactions observed were of types 4 and 5 (the least important), with a total number of 2712 cases of interactions, accounting for 68.5% of the total number of interactions observed.
Table 2. Frequency
distribution of 598 number of interactions ( 80 types) observed in the CCU
ward of Bou-Ali hospital.
Parameter studied
Number of
Interactions
Percentage of interactions
Type of
Interactions
Percentage of interactions
Significance of interactions:
1.0
2.0
3.0
4.0
5.0
39
89
36
238
196
6.5
14.9
6.0
39.8
32.8
7
8
6
32
27
8.7
10.0
7.5
40.0
33.8
Onset of action:
Delayed
Rapid
193
405
32.3
67.8
40
40
50.0
50.0
Severity of interactions:
Major
Moderate
Minor
47
325
226
7.9
54.3
37.8
10
41
29
12.5
51.2
36.3
Documentation of interactions:
Established
Probable
Suspected
Possible
Unlikely
15
106
44
398
35
2.5
17.8
7.4
66.5
5.8
3
10
8
48
11
3.7
12.5
10.0
60.0
13.8
Table 3.
Frequency distribution of 342 number of interactions ( 58 types) observed
in the ICU ward of Bou-Ali hospital.
Parameter studied
Number of
interactions
Percentage of interactions
Type of
interactions
Percentage of interactions
Significance of interactions:
1.0
2.0
3.0
4.0
5.0
12
66
4
163
97
3.5
19.3
1.2
47.6
28.4
5
9
2
22
20
8.6
15.5
3.5
37.9
34.5
Onset of action:
Delayed
Rapid
149
193
43.5
56.5
29
29
50.0
50.0
Severity of interactions:
Major
Moderate
Minor
19
245
78
5.5
71.7
22.8
6
32
20
10.3
55.2
34.5
Documentation of interactions:
Established
Probable
Suspected
Possible
Unlikely
13
20
48
205
56
3.8
5.8
14.0
60.0
16.4
6
4
6
36
6
10.3
7.0
10.3
62.1
10.3
Table 4.
Frequency distribution of 1763 number of interactions (151 types) observed
in the internal ward of Bou-Ali hospital.
Parameter studied
Number of
interactions
Percentage of interactions
Type of
interactions
Percentage of interactions
Significance of interactions:
1.0
2.0
3.0
4.0
5.0
122
321
112
479
729
6.9
18.2
6.3
27.2
41.4
10
29
9
46
57
6.6
19.2
6.0
30.5
37.7
Onset of action:
Delayed
Rapid
1064
699
60.4
39.6
91
60
60.3
39.7
Severity of interactions:
Major
Moderate
Minor
163
792
808
9.3
44.9
45.8
13
77
61
8.6
51.0
40.4
Documentation of interactions:
Established
Probable
Suspected
Possible
Unlikely
95
268
168
1052
180
5.4
15.2
9.5
59.7
10.2
10
22
15
86
18
6.6
14.5
9.9
57.0
12.0
Table 5.
Frequency distribution of 1257 number of interactions (131 types) observed
in the infectious ward of Bou-Ali hospital.
Parameter studied
Number of
interactions
Percentage of interactions
Type of
interactions
Percentage of interactions
Significance of interactions:
1.0
2.0
3.0
4.0
5.0
134
277
36
229
581
10.7
22.0
2.9
18.2
46.2
6
27
5
37
56
4.6
20.6
3.8
28.2
42.8
Onset of action:
Delayed
Rapid
805
452
64.0
36.0
81
50
61.8
38.2
Severity of interactions:
Major
Moderate
Minor
98
507
652
7.8
40.3
51.9
10
67
54
7.7
51.0
41.3
Documentation of interactions:
Established
Probable
Suspected
Possible
Unlikely
48
251
138
595
225
3.8
20.0
11.0
47.3
17.9
7
19
11
76
18
5.3
14.5
8.4
58.0
13.8
With regards to the onset of action, the most dominant type of interactions were the delayed ones, with a total number of 2211 cases, representing 55.8% of the total number of interactions observed.
When considering the severity of interactions, moderate interactions were dominant, with a total number of 1869 cases, accounting for 47.2% of the total number of interactions observed.
Finally, in terms of the documentation of interactions observed, the most prevalent interactions were of the "possible" type, with a total number of 2250 cases, accounting for 56.8% of the total number of interactions. "Established" interactions only accounted for 4.3% of all interactions.
Discussion
Drug interaction is a very important issue in drug therapy, especially in pediatric and geriatric patients. In the earlier parts of this article (introduction) some of the results obtained by the other researcher have been mentioned. However, it should be noted that since the protocol for conducting these studies could be somewhat different from that of the present study, variation in the results obtained is expected.
Generally speaking the most prevalent type of interactions observed in our study are types 4 and 5, accounting for 68.5% of all interactions observed. This shows that in most cases the drugs prescribed for patients will not cause any serious or fatal interactions. Nevertheless, 7.7% of all interactions were due to type 1 interactions, meaning that patients life could be at risk and in such cases the physician and nursing staff should keep the patient under close surveillance. Furthermore, the infectious ward had the highest number of type 1 interactions, which is probably due to the nature of treatment and the need for combined drug therapy.
Regarding the onset of action, 55.8% were of the delayed type, which could take up to several days or weeks to occur, needing no immediate concern or medical intervention.
When considering the severity of interactions, 8.2% of all interactions were due to "major" interactions, and in such cases the life of patient could be threatened and immediate medical intervention is required. Furthermore, patients should be kept under close observation to prevent any complications.
In terms of the documentation of interactions observed, only 4.3% of all interactions were due to "established" interactions. It should be noted that proper monitoring of patients, a reduction in the dosage regimen, increasing the dosing intervals, etc. could help to reduce risks of severe drug interactions.
In fact the most important parameter to be considered is to find whether a drug could interact with other drugs, and try to find a way to encounter this problem.
In conclusion, it could be said that in this study drug interactions do not appear to cause a serious problem to the health of patient and process of drug therapy. However, further clinical studies are needed to be carried out in order to investigate the actual clinical occurrence of drug interactions.
Acknowledgement
The authors wish to thank Dr. V. Sedeghi for his assistance with this work.
References
N
ies AS. Principles of therapeutics. In: Hardman JG (Ed) Goodman and Gilmans: The Pharmacological Basis of Therapeutics, 10th ed. New york: Pergamon Press (2001) 4
Stockly LH. Drug Interactions: The Comprehensive World-wide References on Drug Interactions. London: The Pharmaceutical Press, (1999)
Tatro D S. Drug Interaction Facts . 9th ed. St. Louis: Facts and comparisons, (2000)
Galley M, Egbunike L, Maswoswe J, Okpara A and Jackson D. Incidence and severity of drug interaction in patients admitted to the internal medicine service of a large teaching hospital. ASHP midyear clinical meeting (1994) 29: 198E
Borda T, Slon D and Jick H. Assessment of adverse reactions within a drug surveillance program. J. Am. Med. Ass. (1986) 205: 645-7
May JR, Dipiro JT and Sisley JF. Drug interactions in surgical patients. Am. J. Surg. (1987) 153: 327-35
Stanaszek WF and Franklin CE. Survey of potential drug interaction incidence in an outpatient clinic population. Hosp. Pharm. (1978) 13: 255-263
Top